Related Experiment Video
Updated: Jan 15, 2026

05:18
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
1.8K
PlanAct: An eclipse scripting API-based module embedding clinical optimization strategies for automated planning in
Hao Guo1, Tenzin Kunkyab1, Yang Lei1
1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.
Journal of Applied Clinical Medical Physics
|October 9, 2025
Summary
PlanAct significantly improves automated intensity-modulated radiotherapy planning for non-small cell lung cancer, outperforming existing methods and offering better organ-at-risk sparing. This tool enhances treatment consistency and quality for challenging cases.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment
Background:
- Manual intensity-modulated radiotherapy (IMRT) planning for locally advanced non-small cell lung cancer (LA-NSCLC) is resource-intensive.
- Current automated methods like RapidPlan often require manual adjustments for LA-NSCLC to meet clinical objectives.
Purpose of the Study:
- Develop and validate PlanAct, an Eclipse Scripting API (ESAPI)-based module for automated IMRT planning in LA-NSCLC.
- Compare PlanAct's performance against RapidPlan and existing clinical plans.
Main Methods:
- PlanAct was developed with modular functions to automate IMRT plan generation and optimization.
- Executed on 56 retrospective LA-NSCLC cases, evaluating plans against RapidPlan and clinical benchmarks using institutional quality metrics.
- Statistical analysis assessed differences in plan quality and dosimetric requirement fulfillment.
Main Results:
- PlanAct-optimized plans showed superior quality and better organ-at-risk sparing, especially for lungs (p < 0.001 for V20 and Dmean), compared to RapidPlan.
- Significantly fewer unmet clinical requirements with PlanAct (1 plan) versus RapidPlan (18 plans) and clinical plans (10 plans).
- PlanAct demonstrated superior dose distributions and hotspot control, even in complex anatomical cases.
Conclusions:
- PlanAct is an effective tool for optimizing automated IMRT planning in LA-NSCLC.
- Achieved plans comparable to or better than clinical standards, even in challenging patient cases.
- Its modular design shows potential for integration into future autonomous, patient-specific radiotherapy planning systems.
Keywords:
knowledge‐based planningRelated Concept Videos
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Planning Nursing Care I
5.5K
The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
5.5K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

